Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today that its affiliate VGX International Inc. has received approval in Korea to begin a Phase I clinical trial in healthy volunteers for Inovio’s SynCon™ preventive DNA vaccine (VGX-3400) targeting H5N1 avian influenza.
The World Health Organization (WHO) recommended on Thursday that this year’s seasonal flu vaccine in the northern hemisphere should include protection against three strains, including the pandemic H1N1 virus.WHO’s flu expert Keiji Fukuda said the composition, announced after a four-day meeting of experts, means H1N1 swine flu vaccine still held by drugmakers in bulk form may be used for part of …
More here:
H1N1 Strain To Be Included In New Seasonal Flu Vaccine (redOrbit)
Source: Reuters GENEVA, Feb 18 (Reuters) – Vaccine experts recommended on Thursday that the coming year’s seasonal flu vaccine in the northern hemisphere contain three strains, including the pandemic H1N1 virus, …
More here:
New seasonal vaccine to contain pandemic H1N1 strain (AlertNet)
Researchers have developed a rapid, automated system to differentiate strains of influenza.
Continue reading here:
Rapid flu testing differentiates strains of influenza (Science Daily)
Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today that it has filed the application with China’s State Food and Drug Administration (SFDA) to commence a human clinical trial for its vaccine against human enterovirus 71 (EV 71), which causes hand, foot, and mouth disease (HFMD). This is the first clinical trial application for HFMD vaccine submitted …
Original post:
SVA submits the first clinical trial application for HFMD vaccine in China (News-Medical-Net)
TessArae, LLC, a privately held company, and Affymetrix Inc., (NASDAQ:AFFX) today announced that the Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) to TessArae for its TessArray® Resequencing Influenza A Microarray Detection Panel for the Detection of the 2009 H1N1 Influenza A Virus (TessArray RM-Flu test) for the duration of the declaration of emergency unless …
Continued here:
TessArae’s RM-Flu test granted FDA EUA (News-Medical-Net)
NanoViricides, Inc., reports that the Company has filed its quarterly report with the SEC on November 23rd.
Continued here:
NanoViricides announces filing of its quarterly report with the SEC (News-Medical-Net)
On the same evening health officials and medical experts took to the airwaves to answer Rhode Islander’s questions regarding the H1N1 virus, word comes that Rhode Island is being looked at as a model for how other states should be handling H1N1 response.
Follow this link:
RI a Model for H1N1 Response (ABC 6 Providence)
Confused about how many flu shots to get this year and in what order? You’re not alone. There hasn’t been a flu season quite like this.
See the original post here:
H1N1 vaccine will likely be offered in November – UPDATED WITH PHOTO (The North Bay Nugget)
Sanofi Pasteur, the vaccines division of the sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), announced today that the company has received an additional order from the U.S. Department of Health and Human Services (HHS) to produce vaccine to help protect against the Influenza A (H1N1) 2009 virus. The new order is for the production of bulk antigen equivalent to 27.3 million doses based on 15 …
Original post:
Sanofi Pasteur receives additional order H1N1 vaccine (News-Medical-Net)